Infinity Pharmaceuticals, Inc. Contracts Revenue (Deprecated 2018-01-31)
Infinity Pharmaceuticals, Inc. reported Contracts Revenue (Deprecated 2018-01-31) of $0 for the 3-month period ending 2017-12-31, per its 10-K filed 2018-03-15.
Discontinued › Income Statement › Other Income
us-gaap:ContractsRevenue · last filed 2018-03-15
- Infinity Pharmaceuticals, Inc. contracts revenue (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $0.00.
- Infinity Pharmaceuticals, Inc. contracts revenue (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $6.00M.
- Infinity Pharmaceuticals, Inc. contracts revenue (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $0.00, a 100.00% decline year-over-year.
- Infinity Pharmaceuticals, Inc. contracts revenue (deprecated 2018-01-31) for the quarter ending 2017-03-31 was $0.00, a 100.00% decline year-over-year.
- Infinity Pharmaceuticals, Inc. contracts revenue (deprecated 2018-01-31) for fiscal 2017 was $6.00M, a 67.95% decline from fiscal 2016.
- Infinity Pharmaceuticals, Inc. contracts revenue (deprecated 2018-01-31) for fiscal 2016 was $18.72M, a 82.83% decline from fiscal 2015.
- Infinity Pharmaceuticals, Inc. contracts revenue (deprecated 2018-01-31) for fiscal 2015 was $109.07M, a 33.90% decline from fiscal 2014.
- Infinity Pharmaceuticals, Inc. contracts revenue (deprecated 2018-01-31) for fiscal 2014 was $165.00M.
| Period end | Contracts Revenue (Deprecated 2018-01-31) 3 month | Contracts Revenue (Deprecated 2018-01-31) 6 month | Contracts Revenue (Deprecated 2018-01-31) 9 month | Contracts Revenue (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 10-K · filed 2018-03-15 | $6.00M derived: sum of 2 quarters · filed 2018-03-15 | $6.00M derived: sum of 3 quarters · filed 2018-03-15 | $6.00M 10-K · filed 2018-03-15 |
| 2017-09-30 | $6.00M 10-K · filed 2018-03-15 | $6.00M derived: sum of 2 quarters · filed 2018-03-15 | $6.00M 10-Q · filed 2017-11-07 | $6.00M derived: sum of 4 quarters · filed 2018-03-15 |
| 2017-06-30 | $0.00 10-K · filed 2018-03-15 | $0.00 10-Q · filed 2017-08-03 | $0.00 derived: sum of 3 quarters · filed 2018-03-15 | $0.00 derived: sum of 4 quarters · filed 2018-03-15 |
| 2017-03-31 | $0.00 10-K · filed 2018-03-15 | $0.00 derived: sum of 2 quarters · filed 2018-03-15 | $0.00 derived: sum of 3 quarters · filed 2018-03-15 | $9.47M derived: sum of 4 quarters · filed 2018-03-15 |
| 2016-12-31 | $0.00 10-K · filed 2018-03-15 | $0.00 derived: sum of 2 quarters · filed 2018-03-15 | $9.47M derived: sum of 3 quarters · filed 2018-03-15 | $18.72M 10-K · filed 2018-03-15 |
| 2016-09-30 | $0.00 10-K · filed 2018-03-15 | $9.47M derived: sum of 2 quarters · filed 2018-03-15 | $18.72M 10-Q · filed 2017-11-07 | $27.80M derived: sum of 4 quarters · filed 2018-03-15 |
| 2016-06-30 | $9.47M 10-K · filed 2018-03-15 | $18.72M 10-Q · filed 2017-08-03 | $27.80M derived: sum of 3 quarters · filed 2018-03-15 | $118.55M derived: sum of 4 quarters · filed 2018-03-15 |
| 2016-03-31 | $9.26M 10-K · filed 2018-03-15 | $18.34M derived: sum of 2 quarters · filed 2018-03-15 | $109.08M derived: sum of 3 quarters · filed 2018-03-15 | $113.96M derived: sum of 4 quarters · filed 2018-03-15 |
| 2015-12-31 | $9.08M 10-K · filed 2017-03-14 | $99.82M derived: sum of 2 quarters · filed 2017-03-14 | $104.70M derived: sum of 3 quarters · filed 2017-03-14 | $109.07M 10-K · filed 2018-03-15 |
| 2015-09-30 | $90.74M 10-K · filed 2017-03-14 | $95.62M derived: sum of 2 quarters · filed 2017-03-14 | $99.99M 10-Q · filed 2016-11-09 | $104.34M derived: sum of 4 quarters · filed 2017-03-14 |
| 2015-06-30 | $4.88M 10-K · filed 2017-03-14 | $9.24M 10-Q · filed 2016-08-09 | $13.60M derived: sum of 3 quarters · filed 2017-03-14 | $174.24M derived: sum of 4 quarters · filed 2017-03-14 |
| 2015-03-31 | $4.36M 10-K · filed 2017-03-14 | $8.72M derived: sum of 2 quarters · filed 2017-03-14 | $169.36M derived: sum of 3 quarters · filed 2017-03-14 | |
| 2014-12-31 | $4.36M 10-K · filed 2016-02-23 | $165.00M derived: sum of 2 quarters · filed 2016-02-23 | $165.00M 10-K · filed 2017-03-14 | |
| 2014-09-30 | $160.64M 10-K · filed 2016-02-23 | $160.64M 10-Q · filed 2015-11-05 |